Correlation Between Cyclacel Pharmaceuticals and Senti Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Senti Biosciences, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Senti Biosciences.

Diversification Opportunities for Cyclacel Pharmaceuticals and Senti Biosciences

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cyclacel and Senti is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Senti Biosciences go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and Senti Biosciences

Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to under-perform the Senti Biosciences. In addition to that, Cyclacel Pharmaceuticals is 1.03 times more volatile than Senti Biosciences. It trades about -0.05 of its total potential returns per unit of risk. Senti Biosciences is currently generating about -0.03 per unit of volatility. If you would invest  1,970  in Senti Biosciences on August 29, 2024 and sell it today you would lose (1,756) from holding Senti Biosciences or give up 89.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cyclacel Pharmaceuticals  vs.  Senti Biosciences

 Performance 
       Timeline  
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Senti Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Cyclacel Pharmaceuticals and Senti Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclacel Pharmaceuticals and Senti Biosciences

The main advantage of trading using opposite Cyclacel Pharmaceuticals and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.
The idea behind Cyclacel Pharmaceuticals and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like